Articles

Editors' (re)View: FDA shares early AD industry guidance; WuXi-BIO breakup

March 15, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 11

Anticipating AI regulations in pharma manufacturing

March 11, 2024
In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

Leveraging lean innovation principles

March 11, 2024
How pharma can apply tactics from other industries to tackle recent policy cost initiatives

Charting a sustainable path for generics

March 8, 2024
Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

Editors' (re)View: Perrigo launches OTC birth control; Lilly takes aim at celebs

March 8, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 4

Breaking down pharma compliance barriers

March 7, 2024
How pharma companies are solving regulatory challenges with AI-based technology

Navigating the smaller batch market

March 5, 2024
Pharma innovators are using technology to meet the unique demands of today’s small scale era

FDA decisions to watch in 2024   

March 5, 2024
This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

5 Pharma changemakers

March 1, 2024
The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry

Editors' (re)View: Probing pharma-sponsored testing; FDA approves Alvotech-Teva Humira biosim 

March 1, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 24

Pharma CDMOs with sky-high ambitions

Feb. 29, 2024
A snapshot of the bold CDMOs working to build pharma’s modern treatments

The role of workwear in mitigating pharma workplace hazards

Feb. 28, 2024
Ergonomic clothing explicitly designed for the industry helps avoid common safety incidents, as well as aid in compliance

Matica Biotechnology: Filling the void

Feb. 27, 2024
With a dedication to advanced technologies, the Texas-based CDMO is helping quickly bring cell and gene therapies from idea to patient

INCOG Biopharma: Pedaling towards excellence

Feb. 27, 2024
The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

Cellares: A disruptive impact on cell therapy

Feb. 27, 2024
The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

ten23 health: Sustainable success

Feb. 27, 2024
With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Raising a modern pharma CDMO

Feb. 27, 2024
Four young companies built with intention tackle the future of medicine

What pharma needs to know about transfer pricing

Feb. 26, 2024
Transfer pricing analysis helps companies to manage tax risks as well as identify business opportunities

Editors' (re)View: Landmark approval for solid tumors; Relief for food allergy sufferers 

Feb. 23, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 19

Reframing OEE in pharma

Feb. 21, 2024
Modern technologies can transform overall equipment effectiveness from an operations metric into a valuable source of data

The shape of pharma to come

Feb. 21, 2024
Staying flexible in response to shifting supply chains in 2024

Editors' (re)View: Humira's patent blip; Hope for pancreatic cancer

Feb. 16, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of February 12

Protecting pharma's most valuable asset: intellectual property

Feb. 15, 2024
By taking the necessary precautions, pharma manufacturers can minimize the damage to their company when things go wrong

How real-time metrics can drive quality excellence beyond compliance

Feb. 12, 2024
Establishing foundational quality data and real-time reporting is a priority to reach proactive quality management

Editors' (re)View: Lilly weighs in on Novo deal; J&J drug brings immune disease hope

Feb. 9, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of February 5

5 expert insights on generics and biosimilars

Feb. 8, 2024
Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

Editors' (re)View: CMS commits to improving CGT access; The Aduhelm exit

Feb. 2, 2024
Pharma Manufacturing editors comment on the notable happenings in the pharma industry from the week of January 28

2024 pharma predictions: Regulations, sustainability and culture

Jan. 31, 2024
In part 2 of our series, leaders weigh in on what the pharma industry can expect in the coming year

2024 pharma predictions: Therapeutic advances, manufacturing tech

Jan. 31, 2024
In our two-part series, leaders weigh in on what the pharma industry can expect in the coming year